|
| Heart rate–corrected field potential duration, a surrogate for QTc, was measured in human induced pluripotent stem cells from two patients with long QT syndrome type 2 before and after mexiletine using a multiwell multi-electrode array system. [Circulation] |
|
|
|
 | PUBLICATIONSRanked by the impact factor of the journal |
| |
|
|
| Researchers generated a novel mouse line with constitutive deletion of PANX1 in cardiomyocytes. PANX1 deletion in cardiomyocytes had no effect on unstressed heart function but increased the glycolytic metabolism and resulting glycolytic ATP production. [Circulation Research] |
| |
|
|
| Investigators identified a new regulator of muscle regeneration, deformed epidermal autoregulatory factor-1 (Deaf1) – a transcriptional factor downstream of forkhead box O (foxo) signaling. [Autophagy] |
|
|
|
| Mice underwent moderate-intensity continuous training from nine months0 or 20 months to 25 months, with age-matched and adult controls. Histological examinations and muscle stem cell (MuSC) transplantation assays assessed aerobic exercise effects on MuSC function and muscle regeneration. [Journal of Cachexia Sarcopenia and Muscle] |
| |
|
|
| Scientists investigated whether EDIL3 promoted the internalization and degradation of apoptotic vascular smooth muscle cells during thoracic aortic dissection. [Autophagy] |
|
|
|
| The authors studied the role of tenascin-X in vascular smooth muscle cells (VSMCs) in various murine disease models using tamoxifen-inducible SMC-specific knockout and adeno-associated virus–mediated knockdown. [Arteriosclerosis Thrombosis and Vascular Biology] |
|
|
|
|
| Scientists discuss how epigenetic modifications change during the process of skeletal muscle atrophy, the molecular mechanisms by which epigenetic regulatory proteins control skeletal muscle atrophy, and assess their translational potential. [Cellular & Molecular Biology Letters] |
|
|
|
| Investigators summarize recent findings on the impact of obesity on skeletal muscle mitochondria structure and function, the molecular mechanism of mitochondrial quality control systems, and how obesity impacts these systems. [Current Nutrition Reports] |
|
|
|
|
| An experimental drug designed to treat one of the most common forms of muscular dystrophy successfully reduced levels of a rogue protein that causes the disease, according to preliminary results of a multi-site clinical trial that includes the University of Kansas Medical Center. [University of Kansas Medical Center] |
|
|
|
|
| August 13-17, 2024 Long Island, New York, United States |
|
|
|
|
|
| Oklahoma Medical Research Foundation – Oklahoma City, Oklahoma, United States |
|
|
|
| Indiana University School of Medicine – Indianapolis, Indiana, United States |
|
|
|
| Goethe University Frankfurt am Main – Frankfurt, Germany |
|
|
|
| Indiana University – Indianapolis, Indiana, United States |
|
|
|
| KU Leuven – Leuven, Belgium |
|
|
|
|